BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25267624)

  • 21. The Troyer syndrome protein spartin mediates selective autophagy of lipid droplets.
    Chung J; Park J; Lai ZW; Lambert TJ; Richards RC; Zhang J; Walther TC; Farese RV
    Nat Cell Biol; 2023 Aug; 25(8):1101-1110. PubMed ID: 37443287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DDHD2-STXBP1 interaction mediates long-term memory via generation of saturated free fatty acids.
    Akefe IO; Saber SH; Matthews B; Venkatesh BG; Gormal RS; Blackmore DG; Alexander S; Sieriecki E; Gambin Y; Bertran-Gonzalez J; Vitale N; Humeau Y; Gaudin A; Ellis SA; Michaels AA; Xue M; Cravatt B; Joensuu M; Wallis TP; Meunier FA
    EMBO J; 2024 Feb; 43(4):533-567. PubMed ID: 38316990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.
    Tesson C; Nawara M; Salih MA; Rossignol R; Zaki MS; Al Balwi M; Schule R; Mignot C; Obre E; Bouhouche A; Santorelli FM; Durand CM; Oteyza AC; El-Hachimi KH; Al Drees A; Bouslam N; Lamari F; Elmalik SA; Kabiraj MM; Seidahmed MZ; Esteves T; Gaussen M; Monin ML; Gyapay G; Lechner D; Gonzalez M; Depienne C; Mochel F; Lavie J; Schols L; Lacombe D; Yahyaoui M; Al Abdulkareem I; Zuchner S; Yamashita A; Benomar A; Goizet C; Durr A; Gleeson JG; Darios F; Brice A; Stevanin G
    Am J Hum Genet; 2012 Dec; 91(6):1051-64. PubMed ID: 23176821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the genetic basis of early onset hereditary spastic paraplegia using whole genome sequencing.
    Kumar KR; Wali GM; Kamate M; Wali G; Minoche AE; Puttick C; Pinese M; Gayevskiy V; Dinger ME; Roscioli T; Sue CM; Cowley MJ
    Neurogenetics; 2016 Oct; 17(4):265-270. PubMed ID: 27679996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation.
    Doi H; Ushiyama M; Baba T; Tani K; Shiina M; Ogata K; Miyatake S; Fukuda-Yuzawa Y; Tsuji S; Nakashima M; Tsurusaki Y; Miyake N; Saitsu H; Ikeda S; Tanaka F; Matsumoto N; Yoshida K
    Sci Rep; 2014 Nov; 4():7132. PubMed ID: 25417924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP2U1 activity is altered by missense mutations in hereditary spastic paraplegia 56.
    Durand CM; Dhers L; Tesson C; Tessa A; Fouillen L; Jacqueré S; Raymond L; Coupry I; Benard G; Darios F; El-Hachimi KH; Astrea G; Rivier F; Banneau G; Pujol C; Lacombe D; Durr A; Babin PJ; Santorelli FM; Pietrancosta N; Boucher JL; Mansuy D; Stevanin G; Goizet C
    Hum Mutat; 2018 Jan; 39(1):140-151. PubMed ID: 29034544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
    Fink JK
    Acta Neuropathol; 2013 Sep; 126(3):307-28. PubMed ID: 23897027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35).
    Dick KJ; Eckhardt M; Paisán-Ruiz C; Alshehhi AA; Proukakis C; Sibtain NA; Maier H; Sharifi R; Patton MA; Bashir W; Koul R; Raeburn S; Gieselmann V; Houlden H; Crosby AH
    Hum Mutat; 2010 Apr; 31(4):E1251-60. PubMed ID: 20104589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary spastic paraplegia: report of two siblings.
    Yeh YC; Mak SC; Chi CS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(2):112-5. PubMed ID: 9599901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hereditary spastic paraplegia mouse model supports a role of ZFYVE26/SPASTIZIN for the endolysosomal system.
    Khundadze M; Kollmann K; Koch N; Biskup C; Nietzsche S; Zimmer G; Hennings JC; Huebner AK; Symmank J; Jahic A; Ilina EI; Karle K; Schöls L; Kessels M; Braulke T; Qualmann B; Kurth I; Beetz C; Hübner CA
    PLoS Genet; 2013; 9(12):e1003988. PubMed ID: 24367272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo Evidence for Lysosome Depletion and Impaired Autophagic Clearance in Hereditary Spastic Paraplegia Type SPG11.
    Varga RE; Khundadze M; Damme M; Nietzsche S; Hoffmann B; Stauber T; Koch N; Hennings JC; Franzka P; Huebner AK; Kessels MM; Biskup C; Jentsch TJ; Qualmann B; Braulke T; Kurth I; Beetz C; Hübner CA
    PLoS Genet; 2015 Aug; 11(8):e1005454. PubMed ID: 26284655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in DDHD1, encoding a phospholipase A1, is a novel cause of retinopathy and neurodegeneration with brain iron accumulation.
    Dard R; Meyniel C; Touitou V; Stevanin G; Lamari F; Durr A; Ewenczyk C; Mochel F
    Eur J Med Genet; 2017 Dec; 60(12):639-642. PubMed ID: 28818478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymatic characterization of recombinant rat DDHD2: a soluble diacylglycerol lipase.
    Araki M; Ohshima N; Aso C; Konishi A; Obinata H; Tatei K; Izumi T
    J Biochem; 2016 Nov; 160(5):269-279. PubMed ID: 27198176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for mutations in the phosphatidylinositol 4-kinase 2-alpha gene in autosomal recessive hereditary spastic paraplegia.
    Cleeter M; Houlden H; Simons P; Al-Shawi R; Stevanin G; Durr A; Hsuan J; Warner TT
    Amyotroph Lateral Scler; 2011 Mar; 12(2):148-9. PubMed ID: 21190509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VPS53 gene is associated with a new phenotype of complicated hereditary spastic paraparesis.
    Hausman-Kedem M; Ben-Shachar S; Menascu S; Geva K; Sagie L; Fattal-Valevski A
    Neurogenetics; 2019 Oct; 20(4):187-195. PubMed ID: 31418091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid Droplet-Associated Hydrolase Promotes Lipid Droplet Fusion and Enhances ATGL Degradation and Triglyceride Accumulation.
    Goo YH; Son SH; Paul A
    Sci Rep; 2017 Jun; 7(1):2743. PubMed ID: 28578400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2.
    Noetzli L; Sanz PG; Brodsky GL; Hinckley JD; Giugni JC; Giannaula RJ; Gonzalez-Alegre P; Di Paola J
    Gene; 2014 Jan; 533(1):447-50. PubMed ID: 24103481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in hereditary spastic paraplegia.
    Fink JK
    Curr Opin Neurol; 1997 Aug; 10(4):313-8. PubMed ID: 9266155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ophthalmological changes in hereditary spastic paraplegia and other genetic diseases with spastic paraplegia.
    de Freitas JL; Rezende Filho FM; Sallum JMF; França MC; Pedroso JL; Barsottini OGP
    J Neurol Sci; 2020 Feb; 409():116620. PubMed ID: 31865189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular aspects of hereditary spastic paraplegia.
    Noreau A; Dion PA; Rouleau GA
    Exp Cell Res; 2014 Jul; 325(1):18-26. PubMed ID: 24631291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.